NCT01789060
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
Clinical trial condition
P13K-AKT Pathway Deregulation
Explore clinical trials studying P13K-AKT Pathway Deregulation. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies